drugset / Trial / NCT03555617
Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
RandomizedCrossoverOpen-labelBasic science
Summary
This is a Phase 1, open-label, 2-cohort, food-effect, DDI, and formulation bridging study.
Timeline
- Start
- 2018-06-13
- Primary completion
- 2018-07-15
- Completion
- 2018-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IZENCITINIB | Small molecule | 100 mg | Oral |
| Subject | Itraconazole | Small molecule | 200 mg | Oral |